Related Experiment Videos
Efflux of cyclic GMP from activated human platelets
1University of Konstanz, Faculty of Biology, Konstanz, Germany.
Molecular Pharmacology
|April 1, 1993
Summary
Platelet activation releases cyclic guanosine monophosphate (cGMP) outside cells, decreasing intracellular levels. This efflux, not increased synthesis, drives the apparent cGMP rise during aggregation, favoring platelet activation.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Platelet activation is linked to increased cyclic guanosine monophosphate (cGMP) levels.
- The source and localization of this cGMP increase have been debated.
Purpose of the Study:
- To investigate the intracellular versus extracellular distribution of cGMP during human platelet activation.
- To clarify the role of cGMP changes in platelet aggregation signaling.
Main Methods:
- Measurement of intracellular and extracellular cGMP levels in activated human platelets.
- Distinguishing cGMP changes from direct soluble guanylyl cyclase activation.
Main Results:
- Platelet activation leads to a decrease in intracellular cGMP and accumulation in the extracellular space.
- cGMP is released from platelets during aggregation, escaping intracellular hydrolysis.
- Nitrovasodilators cause cGMP synthesis mainly within cells, unlike platelet agonists.
Conclusions:
- The observed increase in total cGMP during platelet aggregation is due to extracellular release, not increased intracellular synthesis.
- cGMP efflux decreases intracellular levels, potentially promoting platelet activation.
- This mechanism contrasts with the hypothesis of cGMP as a feedback inhibitor of platelet activation.